124 related articles for article (PubMed ID: 31059266)
1. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.
Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H
J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266
[TBL] [Abstract][Full Text] [Related]
2. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
[TBL] [Abstract][Full Text] [Related]
5. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
7. USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1.
Li Z; Cheng Z; Raghothama C; Cui Z; Liu K; Li X; Jiang C; Jiang W; Tan M; Ni X; Pandey A; Liu JO; Dang Y
Nucleic Acids Res; 2018 Jan; 46(2):823-839. PubMed ID: 29228324
[TBL] [Abstract][Full Text] [Related]
8. The X-linked deubiquitinase USP9X is an integral component of centrosome.
Wang Q; Tang Y; Xu Y; Xu S; Jiang Y; Dong Q; Zhou Y; Ge W
J Biol Chem; 2017 Aug; 292(31):12874-12884. PubMed ID: 28620049
[TBL] [Abstract][Full Text] [Related]
9. Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.
Chen X; Zhang X; Cai H; Yang W; Lei H; Xu H; Wang W; Zhu Q; Kang J; Yin T; Gu W; Wu YL
Cancer Lett; 2020 Jan; 469():277-286. PubMed ID: 31605775
[TBL] [Abstract][Full Text] [Related]
10. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3.
Chen W; Song J; Liu S; Tang B; Shen L; Zhu J; Fang S; Wu F; Zheng L; Qiu R; Chen C; Gao Y; Tu J; Zhao Z; Ji J
J Biomed Sci; 2021 Jun; 28(1):44. PubMed ID: 34112167
[TBL] [Abstract][Full Text] [Related]
11. DDX3 interacts with USP9X and participates in deubiquitination of the anti-apoptotic protein MCL1.
Lai MC; Chen YP; Li DA; Yu JS; Hung HY; Tarn WY
FEBS J; 2022 Feb; 289(4):1043-1061. PubMed ID: 34606682
[TBL] [Abstract][Full Text] [Related]
12. Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.
Izrailit J; Jaiswal A; Zheng W; Moran MF; Reedijk M
Oncogene; 2017 Feb; 36(8):1048-1057. PubMed ID: 27593927
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase USP9X stabilizes RNA m
Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
[TBL] [Abstract][Full Text] [Related]
15. USP9X destabilizes pVHL and promotes cell proliferation.
Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y
Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496
[TBL] [Abstract][Full Text] [Related]
16. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitylase USP9X maintains centriolar satellite integrity by stabilizing pericentriolar material 1 protein.
Han KJ; Wu Z; Pearson CG; Peng J; Song K; Liu CW
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30584065
[TBL] [Abstract][Full Text] [Related]
18. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
[TBL] [Abstract][Full Text] [Related]
19. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
[TBL] [Abstract][Full Text] [Related]
20. Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains.
Al-Hakim AK; Zagorska A; Chapman L; Deak M; Peggie M; Alessi DR
Biochem J; 2008 Apr; 411(2):249-60. PubMed ID: 18254724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
